Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast

被引:5
作者
Lopez-Bonet, Eugeni [2 ,3 ,4 ]
Carmen Perez-Martinez, Maria [2 ,4 ]
Martin-Castillo, Begona [4 ,5 ]
Alonso-Ruano, Miguel [4 ,6 ]
Tuca, Francesc [4 ,6 ]
Oliveras-Ferraros, Cristina [4 ,7 ]
Cufi, Silvia [4 ,7 ]
Vazquez-Martin, Alejandro [4 ,7 ]
Beltran, Miquel [4 ]
Bernado, Luis [2 ,4 ]
Menendez, Javier A. [1 ,4 ,7 ]
机构
[1] Dr Josep Trueta Univ Hosp, Catalan Inst Oncol Girona, E-17007 Girona, Catalonia, Spain
[2] Dr Josep Trueta Univ Hosp, Dept Anat Pathol, E-17007 Girona, Catalonia, Spain
[3] Autonomous Univ Barcelona, Sch Med UAB, Dept Pathol, E-08193 Barcelona, Catalonia, Spain
[4] Girona Biomed Res Inst IdIBGi, E-17007 Girona, Catalonia, Spain
[5] Catalan Inst Oncol Girona, Unit Clin Res, E-17007 Girona, Catalonia, Spain
[6] Dr Josep Trueta Univ Hosp, Dept Gynaecol, E-17007 Girona, Catalonia, Spain
[7] Catalan Inst Oncol Girona, Unit Translat Res, E-17007 Girona, Catalonia, Spain
关键词
APOCRINE DIFFERENTIATION; EXPRESSION; CANCER; TUMORS; FEATURES; MARKERS; EGFR;
D O I
10.1007/s10549-010-1229-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:241 / 244
页数:4
相关论文
共 17 条
[1]   Mammaglobin vs GCDFP-15 - An immunohistologic validation survey for sensitivity and specificity [J].
Bhargava, Rohit ;
Beriwal, Sushil ;
Dabbs, David J. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (01) :103-113
[2]   Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFR [J].
Bhargava, Rohit ;
Beriwal, Sushil ;
Striebel, Joan M. ;
Dabbs, David J. .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (02) :113-118
[3]   A novel aspartyl proteinase from apocrine epithelia and breast tumors [J].
Caputo, E ;
Manco, G ;
Mandrich, L ;
Guardiola, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7935-7941
[4]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[5]  
Ellis I., 2003, PATHOLOGY GENETICS B, V3rd, P9
[6]   Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells [J].
Esparis-Ogando, A. ;
Ocana, A. ;
Rodriguez-Barrueco, R. ;
Ferreira, L. ;
Borges, J. ;
Pandiella, A. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1860-1869
[7]   Neuroendocrine differentiated breast carcinoma:: imaging features correlated with clinical and histopathological findings [J].
Günhan-Bilgen, I ;
Zekioglu, O ;
Ustün, EE ;
Memis, A ;
Erhan, Y .
EUROPEAN RADIOLOGY, 2003, 13 (04) :788-793
[8]   Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast [J].
Honma, N ;
Takubo, K ;
Akiyama, F ;
Sawabe, M ;
Arai, T ;
Younes, M ;
Kasumi, F ;
Sakamoto, G .
HISTOPATHOLOGY, 2005, 47 (02) :195-201
[9]  
KAWASAKI T, 2010, CYTOPATHOLOGY
[10]   Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling [J].
López-Bonet, Eugeni ;
Alonso-Ruano, Miguel ;
Barraza, Graciela ;
Vazquez-Martin, Alejandro ;
Bernado, Luis ;
Menendez, Javier A. .
ONCOLOGY REPORTS, 2008, 20 (06) :1369-1374